Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks

Cited by (277)

Items 201–277 of 277

  1. Discovery of the U2AF1-UHM Inhibitor That Possesses Anti-Leukemia Activity In Vitro
    Amol D. Patil, Mona Kazemi Sabzvar, Xinrui Yuan, Daniel Mohr Collier, Chao‐Yie Yang · 2025 · ACS Medicinal Chemistry Letters
  2. Expression analysis of androglobin and its influence on the transcriptome in cancer
    Carina Osterhof, Michel Seiwert, Stefan Mündnich, Teng Wei Koay, Elena Porto, Glen Kristiansen, David Hoogewijs, Thomas Hankeln · 2025 · Gene
  3. Age-related aberrant alternative splicing as a prognostic tool in older breast cancer patients
    Mengxin Chen, Taiping Xiao, Ke Hao, Chun Ye, Yu Fan, Jianbin Su, Shixin Yang, Yun Feng, Huaimeng Xu, Shiting Fu et al. · 2025 · Communications Biology
  4. Large-scale analysis reveals splicing biomarkers for tuberculosis progression and prognosis
    Hongli Lai, Mengyuan Lyu, Hongxia Ruan, Yang Liu, Tangyuheng Liu, Shuting Lei, Yuling Xiao, Shu Zhang, Binwu Ying · 2024 · Computers in Biology and Medicine
  5. Whole‑exome sequencing insights into synchronous bilateral breast cancer with discordant molecular subtypes
    Shi-Han Hu, Bo Gao, Zhengjin Li, Ya-Chen Yuan · 2024 · Oncology Letters
  6. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro
    Muhammad Choudhry, Yaser Gamallat, Sunita Ghosh, Tarek A. Bismar · 2023 · International Journal of Molecular Sciences
  7. Tumorigenic de-differentiation: the alternative splicing way
    Debleena Ray, David Mark Epstein · 2020 · Molecular & Cellular Oncology
  8. HSPA5 regulates the expression and alternative splicing of inflammatory and immune response genes.
    Heng Fan, Linping Xue, Yujin Liu, Dongmei Zuo, Fei Gao, Huarong Li, Lijuan Zhang, Zhexing Shou · 2021 · Research Square
  9. Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome
    Jingru Sui, Dan Huai Guo, Wen Xiao, Lei Zhou, Yue Huang, Haoyu Yu, Jinyu Chen, Zhaoqi Liu · 2024 · Advanced Science
  10. Transcripts of splicing factors with time-varying associations with survival outcomes in colorectal cancer
    Yajun Yu · 2025 · American Journal of Cancer Research
  11. Genome-Wide Identification of Microglia-Related RNA-Binding Proteins and Regulated Alternative Splicing in Spinal Cord Injury
    Wenbo Gu, Xiao Zhang, Xiaoya Yuan, Lihong Hu, Xusheng Li, Di Luo, Haifeng Yuan · 2025 · ACS Omega
  12. CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation
    Jinyu Li, Ning Wang, Jianlei Bi, Mei-Hua Guo, Bingbing Xu, Ge-Na Huang · 2025 · Frontiers in Genetics
  13. ZC3H12D and DDX5 Antagonistically Regulate Cyclin D1 mRNA Stability and Cell Cycle Progression in Breast Cancer
    Liang Sun, Xueting Liu, Wenbao Lu · 2025 · Cancer Medicine
  14. CIRBP exerts neuroprotective effects in ischemic injury by inhibiting IFN-I signaling
    Dang Tang, Jiang Long, Bibo Gao, Zhongkun Ren · 2026 · Life Sciences
  15. An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups
    Ricardo Blázquez‐Encinas, Víctor García‐Vioque, Andrea Mafficini, Luca Landoni, Daniel Ruiz-Palacios, Laura Gutiérrez-Camacho, María Trinidad Moreno-Montilla, Nicolas Alcala, Sebastián Ventura, Eduardo Eyras et al. · 2026 · Endocrine Pathology
  16. Increasing evidence for the presence of alternative proteins in human tissues and cell lines
    Rodrigo Fernandes Ramalho, Dirce Maria Carraro · 2017 · Applied cancer research/Applied Cancer Research
  17. Interactive Alternative Splicing Analysis of Human Stem Cells Using psichomics
    Nuno Saraiva-Agostinho, Nuno L. Barbosa‐Morais · 2020 · Methods in molecular biology
  18. Two novel RNA-binding proteins identification through computational prediction and experimental validation
    Juan Xie, Xiaoli Zhang, Jinfang Zheng, Xu Hong, Xiaoxue Tong, Xudong Liu, Yaqiang Xue, Xuelian Wang, Yi Zhang, Shiyong Liu · 2021 · Genomics
  19. The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application
    Yao‐Jie Pan, Bowen Liu, Dong‐Sheng Pei · 2022 · DNA and Cell Biology
  20. Unraveling immune heterogeneity across pan-cancer and deep insights in lung adenocarcinoma based on alternative splicing
    Yuquan Wang, Erliang Guo, Min Zou, Chen Lv, Yanrui Cui, Songmei Zhai, Shaocong Sang, Kai Xiong, Xiuqi Yang, Shuping Zhuang et al. · 2024 · Journal of Leukocyte Biology
  21. Modularized Perturbation of Alternative Splicing Across Human Cancers
    Yabing Du, Shoumiao Li, Ranran Du, Ni Shi, Seiji Arai, Sai Chen, Aijie Wang, Yu Zhang, Zhaoyuan Fang, Tengfei Zhang et al. · 2019 · Frontiers in Genetics
  22. Tumor Niche Disruption and Metastasis: The Role of Epithelial-Mesenchymal Transition (EMT)
    Rita Zilhão, Hélia Neves · 2019 · Learning materials in biosciences
  23. Alternative Splicing Changes As Drivers Of Cancer
    Héctor Climente-González, Eduard Porta‐Pardo, Adam Godzik, Eduardo Eyras · 2017 · Zenodo (CERN European Organization for Nuclear Research)
  24. Dysregulated Alternative Splicing Landscape Identifies Intron Retention as a Hallmark and Spliceosome as a Therapeutic Vulnerability in Aggressive Prostate Cancer
    Dingxiao Zhang, Qiang Hu, Yibing Ji, Hsueh‐Ping Chao, Amanda Tracz, Jason S. Kirk, Silvia Buonamici, Ping Zhu, Jianmin Wang, Song Liu et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  25. A Localization Screen Reveals Translation Factories and Widespread Co-Translational Protein Targeting
    Racha Chouaib, Adham Safieddine, Xavier Pichon, Oh Sung Kwon, Aubin Samacoïts, Abdel-Meneem Traboulsi, Nikolay Tsanov, Marie-Cécile Robert, Ina Poser, Christophe Zimmer et al. · 2019 · SSRN Electronic Journal
  26. Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicine
    Ziying Zhang, Peng Chen, Fangyi Liu, Censhan Lin, Ru Deng, Liyan Wu, Yun Cao, Jing‐Ping Yun, Yuhua Huang · 2022 · Research Square
  27. BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia
    Laura López-Hernández, Stephanie J. Crowley, Sara Cea-Sánchez, Ricardo de Arellano, Neetij Krishnan, Patrick Toolan-Kerr, Lynn S. White, Domenico Ignoti, Emily Soto-Hidalgo, Stefano Gustincich et al. · 2026 · Science Advances
  28. Large-scale study of rna processing alterations in multiple cancers
    Babita Singh · 2017 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  29. Characterization of clinically relevant RNA alterations for personalized cancer medicine
    Trincado Alonso, Juan José Quirós Luis · 2019 · Repositori digital de la UPF (Universitat Pompeu Fabra)
  30. Peer Review #1 of "Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma (v0.1)"
    2020 · PeerJ
  31. ASpediaFI: Functional interaction analysis of alternative splicing events
    Doyeong Yu, Kyubin Lee, Daejin Hyung, Soo Young Cho, Charny Park · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  32. RNA-binding protein FXR1 drives cMYC translation by mRNA circularization through eIF4F recruitment in ovarian cancer
    Jasmine George, Yongsheng Li, Deepak Parashar, Shirng‐Wern Tsaih, Prachi Gupta, Anjali Geethadevi, Ishaque P. Kadembari, Chandrima Ghosh, Yunguang Sun, Ramani Ramchandran et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Splicing and Alternative Splicing and the Impact of Mechanics
    Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
  34. Systematic Analysis of the Function and Prognostic Value of RNA-Binding Proteins in Hepatocellular Carcinoma
    TONG WU, Zhiyun Yang, Yuying Yang, Yuyong Jiang, Peipei Meng, Huimin Liu, Qiaoli Zhang · 2020 · Research Square
  35. Targeted exome sequencing for the identification of common mutational signatures and potential driver mutations for brain metastases and prognosis.
    Dainan Zhang, Xi Wang, Shunchang Ma, Peiliang Li, Fei Xue, Beibei Mao, Xiudong Guan, Wenjianlong Zhou, Jiayi Peng, Kun Su et al. · 2021 · PubMed Central
  36. Characterization of the relationship between two RBM5 family members
    Julie J. Loiselle · 2017 · Lu Zone Ul (Laurentian University)
  37. MBNL1 and RBFOX1 co-regulate alternative splicing events transcriptome-wide through a conserved buffering mechanism
    Melissa A. Hale, Joseph Ellis, Ryan C. Meng, Sunny McDaniel, Amy E. Mahady, Stacey D. Wagner, Jared I. Richardson, Ona L. McConnell, Eric T. Wang, J. Andrew Berglund · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  38. RBM10 Interacts with CTBNNBIP1 and Represses Lung Adenocarcinoma Progression Through the Wnt/β- catenin Pathway
    Yingyue Cao, Xin Wang, Qingwei Meng, Jianxiong Geng, Shanqi Xu, Yaoguo Lang, Yongxu Zhou, Lishuang Qi, Zijie Wang, Zixin Wei et al. · 2021 · Research Square
  39. A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1
    Adrià Closa, Marina Reixachs‐Solé, Antonio C. Fuentes-Fayos, Katharina E. Hayer, Juan Luis Melero, Fabienne R. S. Adriaanse, Romy S. Bos, Manuel Torres-Diz, Stephen P. Hunger, Kathryn G. Roberts et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Identification of Necroptosis-related Subtypes, Construction of a Prognosis Model, and Characterization of Immune Infiltration in Colon Cancer.
    Jianli Chen, Yu-ning Qin, Lei Yang, Xiangen Jia, Guozhi Zhang · 2022 · Research Square
  41. A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1
    Adrià Closa, Marina Reixachs‐Solé, Antonio C. Fuentes-Fayos, Katharina E. Hayer, Juan Luis Melero, Fabienne R. S. Adriaanse, Romy S. Bos, Manuel Torres-Diz, Stephen P. Hunger, Kathryn G. Roberts et al. · 2022 · Research Square
  42. Identification of necroptosis-Related subtypes,the development of a prognosis model, and characterization of tumor microenvironment infiltration in Hepatocellular carcinoma
    Guozhi Zhang, Xiangen Jia, Yu-ning Qin · 2022 · Research Square
  43. Peer Review #2 of "Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma (v0.2)"
    2020 · PeerJ
  44. Peer Review #2 of "Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma (v0.1)"
    2020 · PeerJ
  45. Desregulación del splicing del gen PALB2 en cáncer de mama hereditario
    Alberto Valenzuela‐Palomo · 2022
  46. Predicting the effects of cultivation condition on gene regulation in Escherichia coli by using deep learning
    Mun Su Kwon, Joshua Julio Adidjaja, Hyun Uk Kim · 2023 · Computational and Structural Biotechnology Journal
  47. A Systematic Identification of RBPs Driving Aberrant Splicing in Cancer
    Marian Gimeno, César Lobato‐Fernández, Ane San Martín, Ana Anorbe, Ángel Rubio, Juan A. Ferrer-Bonsoms · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Performing Cancer Diagnosis via an Isoform Expression Ranking-based LSTM Model
    Óscar Reyes, Eduardo Pérez · 2023 · ACM Transactions on Intelligent Systems and Technology
  49. DeepRBP: A novel deep neural network for inferring splicing regulation
    Joseba Sancho-Zamora, Juan A. Ferrer-Bonsoms, Danel Olaverri-Mendizabal, Fernando Carazo, Luis V. Valcárcel, Idoia Ochoa · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Chemokine‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients
    Wenjie Zhu, Shimin Zhao, Xiufeng Cheng, Changlei Wu, Zitao Liu, Jun Huang · 2024 · International Immunopharmacology
  51. A Systematic Identification of RBPs Driving Aberrant Splicing in Cancer
    César Lobato‐Fernández, Marian Gimeno, Ane San Martín, Ana Anorbe, Ángel Rubio, Juan A. Ferrer-Bonsoms · 2024 · Research Square
  52. An integrative RNA spliceosomic landscape of pancreatic neuroendocrine tumors unveils novel clinicomolecular associations
    Ricardo Blázquez‐Encinas, Víctor García‐Vioque, Andrea Mafficini, Luca Landoni, María Trinidad Moreno-Montilla, Nicolas Alcala, Sebastián Ventura, Eduardo Eyras, Salvatore Paiella, Roberto Salvia et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  53. UBE2N modulates osteoclast differentiation via BTK-PLCγ2-Ca2+ signaling pathway to promote osteoporosis
    Yiqing Chen, Ruixue Ying, Liya Ai, Fang Dai, Qiu Zhang, Ping Wang, Fuhua Chen · 2025 · Experimental Gerontology
  54. Aberrant alternative splicing in alcoholic hepatitis: regulatory roles of RBPs and sQTLs
    Jinjiang Zhao, Jie Jun Cheng, Shaohua Liang, Wei Guo, Beibei Zhao, Huipeng Zhang, Xianghuang Mei, Ning Zhang, Meifang Sheng · 2025 · BMC Gastroenterology
  55. Comprehensive analysis of aberrant alternative splicing and RNA binding proteins associated with age-related sensorineural hearing loss
    Wei Yu, Zeping Qin, XinYu Liang, Xianbai Zhu, Guojing Tan, Baiyang Ren, Yanghong Xiang, Can Zou, Xueqin Zhou, Hongyang Wang et al. · 2025 · Scientific Reports
  56. Additional file 14 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  57. Additional file 12 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  58. Additional file 8 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  59. Additional file 16 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  60. Additional file 13 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  61. Additional file 10 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  62. Additional file 11 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  63. Additional file 3 of Alternative splicing level related to intron size and organism complexity
    Yang, Pengcheng, Depin Wang, Kang, Le · 2021 · Figshare
  64. Overexpression of USP36 stabilizes RBM28 via deubiquitination, leading to p53 suppression and poor prognosis in colorectal cancer
    Dimitra Sofia Georgiou, Ioanna Maria Karagianni · 2023 · Archive of International Journal of Cancer and Allied Science
  65. The SF3B1 inhibitor pladienolide B massively inhibits DNA damage signaling and repair and counteracts resistance to platinum salts in Non-Small Cell Lung Cancer
    Nour Jamal-El-Hussein, Shipra Chaudhary, Élodie Montaudon, Fariba Némati, Aurélie Genoux, Hélène Polvèche, Rania El Botty, Caroline Barette, Tao Jia, Didier Auboeuf et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  66. The Landscape and Regulatory Mechanisms of Aberrant Alternative Splicing Events in Adenomyosis
    Y. Zhang, Z. Cui · 2025 · Molecular Biology
  67. Integrative Analysis of Alternative Splicing Regulation Reveals Genetic and RBP-Mediated Mechanisms in Endometriosis Pathogenesis
    Zhujie Wang, Haiwei Yan, Lihua Zhu, Shanshan Ni, Lili Qian, Mengjia Yu, Juan Yu · 2026 · Reproductive Sciences
  68. Études d'association génome entier guidées par des réseaux
    Héctor Climente-González · 2020 · theses.fr (ABES)
  69. Systematic imaging of single transcripts and polysomes reveals a widespread transport mechanism dependent on nascent translation
    Adham Safieddine · 2019
  70. Approche à large échelle visant à détecter de nouveaux régulateurs de l'épissage alternatif au cours de la transition épithélio-mésenchymateuse.
    Jean-Philippe Villemin · 2020 · theses.fr (ABES)
  71. The Role of Convergent Transcription in Regulating Alternative Splicing : Targeted Epigenetic Modification via Repurposed CRISPR/Cas9 System and Its Impact on Alternative Splicing Modulation
    Jia Yi · 2020 · theses.fr (ABES)
  72. Integrated RNA-seq and sQTL analysis reveal immune and splicing regulatory features underlying relapse and remission after treatment of Graves’ disease
    Yang Wu, Jie Liu, Yu Yang, Keping Chen, Fei Hua, K J Wang · 2026 · Frontiers in Endocrinology
  73. NF1 splicing reprograms ERα signaling to promote luminal breast cancer progression
    Patrick S. Dischinger, Ian Beddows, Sophia Agrusa, Marie Adams, Emily Wolfrum, Carrie R. Graveel, Matthew R. Steensma · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  74. MBNL1-mediated alternative splicing in cancer: underlying mechanism, isoform regulation, and translational perspectives
    Huidan Tan, Rongyan Zhao, Bo Liu, Leilei Fu · 2026 · Frontiers in Molecular Biosciences
  75. MBNL1-dependent alternative splicing promotes neuronal differentiation through regulation of NUMA1 exon 16 during fibroblast-to-neuron reprogramming
    J Li, Qiu-Shuang Long, Ruoqi Zhang, Bing-Lin Zhu · 2026 · Frontiers in Cell and Developmental Biology
  76. RBFOX3 is associated with neuronal-like phenotypic transition in recurrent glioblastoma
    Xiaomeng Zhang, Jingru Sui, Haoyuan Sun, Ruichao Chai, Z H Liu, Jiguang Wang · 2026 · BMC Cancer
  77. Proteomic Profiling of Endometriosis and Ovarian Endometrioid Carcinoma: A Preliminary Exploratory Study
    Qi Xue, Xianzhong Cheng, Qian Zhao, Li Xiao, Xuening Wang, Luxin Ye, Hongxia Xu, Na Yan, Lin Liu, Xiaohong Yang et al. · 2026 · Technology in Cancer Research & Treatment